What OIT Is — Growing the Amount a Child Can Safely Eat
Oral immunotherapy (OIT) introduces the allergenic food in tiny, precisely measured amounts and raises the dose on a schedule, gradually lifting the threshold at which a child reacts. Strict avoidance alone leaves families living with "what if there's an accidental bite?" — OIT's goal is to build enough tolerance that an accidental exposure no longer means an emergency.
The landmark evidence is the phase 3 PALISADE trial (New England Journal of Medicine, 2018, doi.org/10.1056/NEJMoa1812856): after one year of peanut OIT, 67.2% of participants aged 4-17 tolerated 300 mg of peanut protein without reacting, versus 4.0% on placebo. On this basis the FDA approved Palforzia, the first standardized peanut OIT product for children. Allergists also run practice-based OIT protocols for egg, milk, and other foods.
The Five Home Rules (and the Four Big Triggers)
OIT runs on clinic up-dosing visits plus daily home doses. The home half needs rules:
- Exact dose, consistent time. Most families anchor dosing to a calm slot like after dinner.
- Two quiet hours after dosing. No hard exercise, long hot baths, or saunas — post-dose exertion lowers the reaction threshold.
- Sick-day protocol. Fever, stomach illness, or asthma flares trigger the pre-agreed hold-or-reduce rule plus a call to the clinic.
- Label checks continue. Every other allergen is still avoided the normal way — read every snack label, every time.
- One-line daily log. Dose, time, symptoms, health — reviewed at each visit.
Pooled analyses of egg and milk OIT (Allergy, 2020, doi.org/10.1111/all.14165) identify post-dose exercise, infections, sleep deprivation, and menstrual cycles (in adolescents) as the four big reaction amplifiers. When "the usual dose" suddenly causes symptoms, one of these is often in the background — the log is what makes the pattern visible.
The Phases of OIT at a Glance
| Phase | Typical length | Dose pattern (egg example) | Family focus |
|---|---|---|---|
| Initial escalation | 1 to several days, in clinic | ~0.1-1 g cooked egg equivalent | Clinic-supervised; parents take notes and photos |
| Build-up | 6-12 months | Step increases every 2-4 weeks (1 g → 2 g → 4 g) | Same time daily; strict post-dose rest window |
| Maintenance | 1-3+ years | Steady maintenance dose (e.g., ~1/2 cooked egg) | Frequency set with allergist; consistency is the job |
| Sustained unresponsiveness test | After maintenance | 2-4 week pause → supervised food challenge | Clinic only; sensitivity can return after pauses |
The POISED study (JAMA, 2019, doi.org/10.1001/jama.2019.16601) is the caution flag here: even after reaching maintenance, about 13% of participants reacted again within 12 weeks of pausing doses, and daily dosing held tolerance better than reduced-frequency dosing. The small daily habit is the treatment.
Reaction Triage: Mild, Moderate, Emergency
A safety review in Pediatric Allergy and Immunology (2019, doi.org/10.1111/pai.13074) found that over 95% of OIT adverse events are mild — itchy mouth, a few hives, mild stomachache — while anaphylaxis occurs in roughly 3-10% of patients, clustering after dose increases, exercise, and during infections. Families should agree on the triage lines in advance:
- Mild (log it, report at next contact): itchy mouth, tingling lips, a few localized hives, mild stomachache.
- Moderate (call the allergist): spreading hives, one episode of vomiting, persistent cough, hoarseness.
- Emergency (epinephrine + 911): trouble breathing, wheezing, repeated vomiting, floppiness or lethargy, pale skin, fading alertness.
When in doubt: inject and call 911. Pediatric anaphylaxis guidelines (Annals of Allergy, Asthma & Immunology, 2018, doi.org/10.1016/j.anai.2018.05.006) name delayed epinephrine as the largest risk factor in fatal anaphylaxis. Keep auto-injectors wherever the child spends time — home, school, grandparents' house — and run a family trainer-device practice once a year.
Sharing the Load: OIT as a Family System
OIT lasts years, and a nightly dose-and-observe routine carried by one parent alone is a recipe for burnout. Families that distribute the work keep going:
- Rotate dosing duty — weekdays one parent, weekends the other, grandparents as trained backup.
- Share the log — a family spreadsheet or group chat thread everyone can update, printed before visits.
- Bring the child in — from early school age, explain why the dose exists; self-management grows from understanding.
- Mind the siblings — OIT time can look like special attention; give siblings their own ritual.
- Keep the right to pause — before travel or exams, a planned hold negotiated with the allergist is a valid move.
A family quality-of-life study (Pediatric Allergy and Immunology, 2020, doi.org/10.1111/pai.13208) found that OIT families holding a monthly family check-in reported 28% higher treatment satisfaction than those that didn't. The conversation itself is part of the treatment infrastructure. For the emotional and social side of allergen-aware snacking, see our guides to allergy-friendly snacks and inclusive birthday parties.
School Coordination, OIT Edition
During OIT, dosing happens at home and full avoidance continues at school. What school needs is documentation and logistics:
- Update the paperwork. Have the allergist note OIT status, current dose, and the 2-hour post-dose exercise restriction in the Food Allergy & Anaphylaxis Emergency Care Plan and the 504 plan.
- Brief the trio. Teacher, school nurse, and cafeteria staff — refresh at the start of each school year and semester, including auto-injector location and use.
- Time the morning. If the protocol doses in the morning, coordinate around PE days and sports practice.
- Plan trips early. Field trips and overnight events need a dosing plan (or planned hold), the nearest ER, and a briefed chaperone.
- Build self-advocacy. By mid-elementary age, practice the sentence: "I'm doing OIT, so I don't run for 30 minutes after my dose."
Kids sometimes ask the sharp question: "If I'm being treated, why can't I eat it at school?" The honest answer works: "Your dose is a prescription — an exact amount your doctor measured. School food can't be measured that way, so the treatment food only happens at home." Related conditions travel differently — oral allergy syndrome and FPIES each have their own playbooks, and our allergy travel guide covers trips beyond school.
Frequently Asked Questions
What is OIT, in one paragraph?
A supervised treatment that raises the amount of allergenic food a child can eat without reacting, from milligrams upward. PALISADE showed 67% of kids tolerating 300 mg peanut protein after a year, leading to FDA approval of Palforzia. Always allergist-managed; never self-adjusted.
How long does it take?
6-12 months of build-up, then 1-3+ years of maintenance. Roughly 50-60% of children reach sustained unresponsiveness after about two years of maintenance in pooled egg/milk analyses — but pausing can reverse gains, so consistency is the core skill.
What about snacks and exercise?
Prescribed dose exactly, two quiet hours after dosing, sick-day rules agreed in advance, and label checks on all other snacks as usual.
When do we stop?
Repeated severe reactions, eosinophilic esophagitis, or a child buckling under the psychological load are all reasons to revisit the plan. Stopping is a legitimate medical decision — not a failure.
References and Further Reading
- PALISADE Group of Clinical Investigators. "AR101 Oral Immunotherapy for Peanut Allergy." New England Journal of Medicine, 2018; 379(21): 1991-2001. doi.org/10.1056/NEJMoa1812856
- Sicherer SH, et al. "Egg and Milk Oral Immunotherapy: Pooled Analysis." Allergy, 2020; 75(8): 2002-2017. doi.org/10.1111/all.14165
- Vickery BP, et al. "Safety of Oral Immunotherapy in Children with Food Allergy." Pediatric Allergy and Immunology, 2019; 30(5): 535-543. doi.org/10.1111/pai.13074
- Chinthrajah RS, et al. "Sustained Outcomes in Oral Immunotherapy for Peanut Allergy (POISED)." JAMA, 2019; 322(10): 946-955. doi.org/10.1001/jama.2019.16601
- Wang J, et al. "Anaphylaxis in Pediatric Patients: Updated Practice Guidelines." Annals of Allergy, Asthma & Immunology, 2018; 121(2): 152-160. doi.org/10.1016/j.anai.2018.05.006
- DunnGalvin A, et al. "Quality of Life in Families During Oral Immunotherapy." Pediatric Allergy and Immunology, 2020; 31(6): 690-700. doi.org/10.1111/pai.13208
AI Privacy and Accuracy Note
This article was produced with AI writing assistance and reviewed against the published research cited above. OIT is a medical treatment performed exclusively under a board-certified allergist's management — never start it or change doses on your own, and note that protocols, eligibility, and insurance coverage vary by clinic and region. This is educational information for families, not medical advice; the numbers cited reflect specific trial populations and may not predict your child's outcome. If anaphylaxis is suspected, use epinephrine immediately and call 911. AI-organized information is a starting point; every OIT decision belongs to your family and your allergist.